Skip to main content

Table 3 Radiotherapy details of cervical cancer patients treated during 2008–2017

From: Evolution of patterns of care for women with cervical cancer in Morocco over a decade

 

Period of diagnosis

Total

2008–2012

2013–2017

n (%)

n (%)

n (%)

Patients who received treatment

472

317

789

Patients who received radiotherapy

437 (92.6)

282 (89.0)

719 (91.1)

 EBRT and brachytherapy

226 (51.7)

100 (35.5)

326 (45.3)

 EBRT alone

171 (39.1)

151 (53.5)

322 (44.8)

 Brachytherapy alone

35 (8.0)

24 (8.5)

59 (8.2)

 Unknown

5 (1.1)

7 (2.5)

12 (1.7)

Patients who received brachytherapy

261

124

385

Brachytherapy type

 Low dose rate

178 (68.2)

13 (10.5)

191 (49.6)

 High dose rate

83 (31.8)

111 (89.5)

194 (50.4)

Patients who received

Concomitant CT-RT (chemoradiation)

233 (53.3)

147 (52.1)

380 (52.9)

If radiotherapy was received before or after registration at oncology centre

 Before

20 (4.6)

23 (8.5)

43 (6.1)

 After

413 (95.4)

247 (91.5)

660 (93.9)

 Missing

4 (0.9)

12 (4.3)

16 (2.2)

EBRT total

397

251

648

Duration (weeks)

  < 4

58 (15.7)

21 (9.5)

79 (13.4)

 4–6

198 (53.5)

113 (51.1)

311 (52.6)

 7–8

44 (11.9)

22 (10.0)

66 (11.2)

 9 + 

70 (18.9)

65 (29.4)

135 (22.8)

Total duration of radiotherapy (weeks)

  < 10

137 (85.1)

48 (61.5)

185 (77.4)

 10–12

9 (5.6)

10 (12.8)

19 (7.9)

 13–14

7 (4.3)

7 (9.0)

14 (5.9)

 15 + 

8 (5.0)

13 (16.7)

21 (8.8)

Hospitalization for radiotherapy

61

9

70

  1. EBRT External beam radiation therapy, CT-RT Concurrent chemo–Radiation therapy